{"id":"g-csf-epo","safety":{"commonSideEffects":[{"rate":null,"effect":"Bone pain"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Thrombosis"},{"rate":null,"effect":"Splenomegaly"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Granulocyte-Colony Stimulating Factor (G-CSF) acts on hematopoietic progenitor cells to promote neutrophil differentiation and mobilization, while Erythropoietin (EPO) stimulates erythroid progenitors to increase red blood cell production. The combination aims to synergistically restore bone marrow function and improve oxygen delivery, potentially beneficial in conditions with compromised hematopoiesis such as liver disease or cirrhosis.","oneSentence":"G-CSF stimulates neutrophil production while EPO stimulates red blood cell production, together enhancing hematopoietic recovery and tissue oxygenation.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:13:39.153Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Decompensated liver cirrhosis with bone marrow dysfunction"},{"name":"Hepatic encephalopathy with hematologic complications"}]},"trialDetails":[{"nctId":"NCT04294641","phase":"PHASE2","title":"Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2021-05-10","conditions":"Chronic GVHD","enrollment":10},{"nctId":"NCT07255612","phase":"PHASE2","title":"Bone Marrow Protection, Safety, Efficacy of Trilaciclib and Eribulin in Locally Advanced or Metastatic TNBC(Triple-negative Breast Cancer)","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2026-11-04","conditions":"Breast Cancer","enrollment":29},{"nctId":"NCT07131280","phase":"NA","title":"National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Single vs Repeated Cycle of Granulocyte Colony-Stimulating Factor (GCSF) & Darbepoetin in Early Decompensated Cirrhosis","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2025-09","conditions":"Decompensated Cirrhosis","enrollment":110},{"nctId":"NCT07002827","phase":"NA","title":"Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standard Medical Treatment on Immunometabolic Profile in Patient With Early Decompensated Cirrhosis.","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2025-05-30","conditions":"Decompensated Liver Cirrhosis","enrollment":60},{"nctId":"NCT01196715","phase":"PHASE3","title":"Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes","status":"COMPLETED","sponsor":"Barts & The London NHS Trust","startDate":"2010-11-01","conditions":"Myelodysplastic Syndrome","enrollment":360},{"nctId":"NCT06364150","phase":"PHASE3","title":"Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial Infarction","status":"RECRUITING","sponsor":"Seoul National Hospital","startDate":"2024-07-15","conditions":"Acute Myocardial Infarction","enrollment":30},{"nctId":"NCT05931718","phase":"","title":"Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia","status":"RECRUITING","sponsor":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","startDate":"2019-06-01","conditions":"Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, Chronic Idiopathic Neutropenia","enrollment":200},{"nctId":"NCT00146562","phase":"PHASE2","title":"Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer","status":"COMPLETED","sponsor":"Harold J. Burstein, MD, PhD","startDate":"2003-07","conditions":"Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer","enrollment":135},{"nctId":"NCT00003138","phase":"PHASE3","title":"Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"1998-03-04","conditions":"Anemia, Myelodysplastic Syndromes","enrollment":118},{"nctId":"NCT05907499","phase":"PHASE3","title":"Decitabine for Poor Graft Function Post Allo-HSCT","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2023-07-01","conditions":"Poor Graft Function","enrollment":76},{"nctId":"NCT00049348","phase":"PHASE2","title":"Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"2003-10-13","conditions":"Pancreatic Cancer","enrollment":""},{"nctId":"NCT05669079","phase":"PHASE3","title":"Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2023-08-01","conditions":"Poor Graft Function","enrollment":100},{"nctId":"NCT02018406","phase":"PHASE1, PHASE2","title":"Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2011-07-05","conditions":"Neurological Diseases, Ischemic Stroke, Hemorrhagic Stroke","enrollment":60},{"nctId":"NCT00058422","phase":"PHASE2","title":"Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2003-02-10","conditions":"Lymphoma","enrollment":65},{"nctId":"NCT00014222","phase":"PHASE3","title":"Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer","status":"COMPLETED","sponsor":"NCIC Clinical Trials Group","startDate":"2000-12-04","conditions":"Breast Cancer","enrollment":2104},{"nctId":"NCT00398047","phase":"PHASE2","title":"Azacitidine, Darbepoetin Alfa, and Erythropoietin and Filgastrim (G-CSF) in Treating Patients With Myelodysplastic Syndromes","status":"TERMINATED","sponsor":"Wake Forest University Health Sciences","startDate":"2006-09","conditions":"Leukemia, Myelodysplastic Syndromes","enrollment":3},{"nctId":"NCT01467115","phase":"PHASE2","title":"Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer","status":"COMPLETED","sponsor":"Drexel University College of Medicine","startDate":"2010-03","conditions":"Head and Neck Cancer","enrollment":1},{"nctId":"NCT01383460","phase":"PHASE3","title":"Efficacy of Granulocyte Colony-stimulating Factor and Erythropoetin for Patients With Acute-on-chronic Liver Failure","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2011-07","conditions":"Acute on Chronic Hepatic Failure","enrollment":55},{"nctId":"NCT01902511","phase":"NA","title":"A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Decompensated Cirrhosis.","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2013-07","conditions":"Decompensated Cirrhosis","enrollment":60},{"nctId":"NCT01048034","phase":"PHASE2","title":"Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)","status":"COMPLETED","sponsor":"Nordic MDS Group","startDate":"2010-01","conditions":"Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia","enrollment":30},{"nctId":"NCT01384565","phase":"PHASE3","title":"G-CSF and Erythropoetin in Survival of Patients With Decompensated Liver Disease","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2011-07","conditions":"Chronic Liver Disease","enrollment":55},{"nctId":"NCT00520468","phase":"PHASE2","title":"Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2004-06","conditions":"Myelodysplastic Syndrome","enrollment":15},{"nctId":"NCT00005787","phase":"PHASE1","title":"Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma","status":"TERMINATED","sponsor":"Northwestern University","startDate":"1999-09","conditions":"Lymphoma, Neutropenia","enrollment":3},{"nctId":"NCT01441427","phase":"PHASE1, PHASE2","title":"Enteral Granulocyte Colony Stimulating Factor and Erythropoietin Early in Life Increases Feeding Tolerance in Preterm Infants: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2010-01","conditions":"Feeding Intolerance, Necrotizing Enterocolitis","enrollment":93},{"nctId":"NCT01356875","phase":"PHASE2","title":"Treatment of Myelodysplastic Syndromes Comparing Hydralazine/Ac. Valproic and Supportive Care in Patients Not Candidates, Refractory and/or Intolerant to Intensive Chemotherapy","status":"UNKNOWN","sponsor":"Basque Health Service","startDate":"2011-09","conditions":"Myelodysplastic Syndrome","enrollment":42},{"nctId":"NCT00298597","phase":"PHASE2","title":"Influence of G-CSF and EPO on Associative Learning and Motor Skills","status":"COMPLETED","sponsor":"University Hospital Muenster","startDate":"2006-03","conditions":"Chronic Stroke, Amyotrophic Lateral Sclerosis","enrollment":180},{"nctId":"NCT00234143","phase":"PHASE2, PHASE3","title":"Erythropoietin (EPO) and Granulocyte-Colony Stimulating Factor (G-CSF) for Low-Risk Myelodysplastic Syndromes (MDS)","status":"UNKNOWN","sponsor":"St. Bartholomew's Hospital","startDate":"2004-10","conditions":"Myelodysplastic Syndromes","enrollment":360},{"nctId":"NCT00501917","phase":"PHASE2, PHASE3","title":"MAGIC Cell-5-Combicytokine Trial","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2007-03","conditions":"Acute Myocardial Infarction","enrollment":116},{"nctId":"NCT00002255","phase":"PHASE1","title":"An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)","status":"COMPLETED","sponsor":"Amgen","startDate":"","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT00002281","phase":"NA","title":"A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex","status":"COMPLETED","sponsor":"Amgen","startDate":"","conditions":"HIV Infections, Cytopenias","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":35,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"G-CSF+EPO","genericName":"G-CSF+EPO","companyName":"Institute of Liver and Biliary Sciences, India","companyId":"institute-of-liver-and-biliary-sciences-india","modality":"Small molecule","firstApprovalDate":"","aiSummary":"G-CSF stimulates neutrophil production while EPO stimulates red blood cell production, together enhancing hematopoietic recovery and tissue oxygenation. Used for Decompensated liver cirrhosis with bone marrow dysfunction, Hepatic encephalopathy with hematologic complications.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}